Date(s) - 10/11/2016 - 12/11/2016
All Day



Title: “Go for it – the many flavors of investigative dermatology”

Supported by educational grants from:


The goal of this initiative is to encourage young gifted dermatologists to further pursue their academic careers through guidance and mentoring of established scientists in the field. Besides scientific sessions, there is a strong emphasis on encouraging young people to network and to exchange ideas. The ESDR is convinced that the Academy is a vital platform for developing European research networks and to foster tomorrow’s leaders in dermatology. The future leaders academy is an excellent opportunity for sponsoring companies to establish sound professional relationships with the next generation of leaders in dermatology.

Applications are reviewed on scientific merit by the ESDR Scientific Program Committee.

General Information

  • Participants must be 40 years old or under by 1 November 2016. Exceptions may be made for career breaks, maternity/paternity leave etc
  • ESDR covers accommodation costs for all participants and travel costs for ESDR members. If you are not a member you may apply prior to the Academy
  • Particants must committ to staying for the entire duration of the Academy
  • All attendees give oral presentations of their work and be expected to attend mentoring events
  • Past participants are not eligble for consideration
  • Residents outside Europe are not eligble for consideration unless they are relocating to Europe within 6 months of the end of the Academy
Thursday 10 November 2016
10.00-12.30 Registration
12.30-13.30 Lunch (seated – mentors/mentees matched)
13.30-14.30 Welcome
Michael Hertl (Germany), Menno de Rie (The Netherlands)
14.30-15.00 Keeping epidermal gene expression under control in health and disease
Caterina Missero (Italy)
15.00-16.30 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)

15.00-15.15 Exploring the pathogenesis of alopecia areata
Marta Bertolini (Germany)

15.15-15.30 The role of Polycomb Repressive Complexes in epidermal differentiation
Andrei Mardaryev (UK)

15.30-15.45 Unusual phenotypes in epidermolytic ichthyosis
Marieke Bolling (The Netherlands)

15.45-16.00 Early genetic and epigenetic events in skin cancer development
Magnus Lynch (UK)

16.00-16.15 Light-independent pro-inflammatory and pro-oxidant effects of purified human hair melanins on keratinocyte cell cultures
Serena Lembo (Italy)

16.15-16.30 Complement system in cutaneous squamous cell carcinoma
Pilvi Riihilä (Finland)

16.30-17.00 Coffee Break
17.00-17.30 Tolerance in mice and men
Kerstin Steinbrink (Germany)
17.30-18.20 Oral presentations by industry partners

Abbvie, Celgene

18.20-19.05 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)

18.20-18.35 Modelling atopic eczema for therapeutic development
Martina Elias (UK)

18.35-18.50 Antisense oligonucleotide RNA-based therapy for epidermolysis bullosa
Peter van den Akker (UK)

18.50-19.05 Innate immune sensing of TLR2/6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells
Yuliya Skabytska (Germany)

19.05-19.45 Break
19.45- Networking Event (transfer by bus from hotel lobby at 19.45)
Friday 11 November 2016
07.00-08.00 Breakfast
08.00-08.30 Experimental investigations of melanoma immunotherapy – Adventures in serendipity
Thomas Tüting (Germany)
08.30-09.00 Chances and Hurdles in Experimental Dermatology
Alexander Navarini (Switzerland)
09.00-10.15 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)

09.00-09.15 Wiskott-Aldrich Syndrome: a model to study the immune pathogenesis of cancer and eczema
Hanna  Brauner (Sweden)

09.15-09.30 Novel therapeutic approaches for dystrophic epidermolysis bullosa based on an increased understanding of the disease
Alexander Nyström (Germany)

09.30-09.45 Dynamics of Neutrophil Extracellular Traps
Luise Erpenbeck (Germany)

09.45-10.00 Hyperactive NRAS downstream signaling induces specific transcriptome changes – esiRNA based identification of new therapeutic targets in NRAS mutant melanoma
Igor Vujic (Austria)

10.00-10.15 Role of IL-36 in Acute Generalized Exanthematous Pustulosis
Barbara Meier (Switzerland)

10.15-11.15 Coffee Break and Group Photo
11.15-11.45 Translational research dedicated to the study of melanocytesThierry Passeron (France)
11.45-12.45 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)

11.45-12.00 Genomic Aberrations in Melanocytic Tumors
Thomas Wiesner (Austria)

12.00-12.15 Melanoma intratumor heterogeneity at the single-cell level
Florian Rambow (Belgium)

12.15-12.30 Mechanisms of Mast cells and T cell interactions during viral infections
Melba Munoz (Germany)

12.30-12.45 The value of observational data in dermatology
Alexander Egeberg (Denmark)

12.45-13.05 Presentation by industry partner


13.05-14.15 Lunch
14.15-15.15 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)

14.15-14.30 Recruitment and activation of proinflammatory human slanDCs by immune complexes
Florina Olaru (Germany)

14.30-14.45 T lymphocytes in atopic dermatitis: New specificities, phenotypes and functions
Lennart Rösner (Germany)

14.45-15.00 The role of T cell subsets in autoimmune bullous diseases
Thomas Schmidt (Germany)

15.00-15.15 Innate-like T cells in human skin: characterising the human lymphoid stress surveillance response
Richard Woolf (UK)

15.15-16.05 Presentations by industry partners

Janssen Cilag, Lilly

16.05-16.30 Coffee Break
16.30- Networking Program (departure from hotel lobby at 16.30)
Saturday 12 November 2016
07.00-08.30 Breakfast
08.30-09.00 Happy Together
Peter Steijlen (The Netherlands)
09.00-09.45 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)

09.00-09.15 Gene-corrected fibroblast therapy for recessive dystrophic epidermolysis bullosa using a SIN COL7A1 retroviral vector
Joanna Jackow (France)

09.15-09.30 Using a novel MS/MS clustering algorithm to analyse tumour heterogeneity in melanoma metastasis
Johannes Griss (Austria)

09.30-09.45 Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma
Laurence Feldmeyer (Switzerland)

09.45-10.15 To D or Not to D?
Mario Fabri (Germany)
10.15-10.45 My Retrospect and Your Future
Mona Stahle (Sweden)
10.45-12.10 Break-out Session/Coffee Break
12.10-12.50 Presentation of Break-out Sessions to Plenum
12.50-13.00 Meeting digest and Outlook
Michael Hertl (Marburg), Menno de Rie (Amsterdam)
13.00 Lunch and departures